FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 208692 | NDA | EXELIXIS INC | | 001 | CABOMETYX | TABLET;ORAL | EQ 20MG BASE | CABOZANTINIB S-MALATE | 2016-04-25 | Prescription | No |
| 002 | CABOMETYX | TABLET;ORAL | EQ 40MG BASE | CABOZANTINIB S-MALATE | 2016-04-25 | Prescription | No |
| 003 | CABOMETYX | TABLET;ORAL | EQ 60MG BASE | CABOZANTINIB S-MALATE | 2016-04-25 | Prescription | Yes |
| 203756 | NDA | EXELIXIS | | 001 | COMETRIQ | CAPSULE;ORAL | EQ 20MG BASE | CABOZANTINIB S-MALATE | 2012-11-29 | Prescription | No |
| 002 | COMETRIQ | CAPSULE;ORAL | EQ 80MG BASE | CABOZANTINIB S-MALATE | 2012-11-29 | Prescription | Yes |